COSTA MESA, Calif., Feb. 4, 2014 /PRNewswire-iReach/ -- Full Service CRO WCCT Global announces today that Dave Peters joins the executive team as Chief Financial Officer. Mr. Peters has over 17 years of Clinical Research experience within the CRO industry. He joins WCCT Global after being with inVentiv Health where he held several senior positions, including CFO of the CRO segment and Sr. VP of Commercial and Corporate Development. Mr. Peters also was part of ICON Clinical Research for approximately 15 years in a number of roles most recently as Sr. VP of Global Finance where he was on the senior team that took ICON through their IPO and helped grow the business from $40M in revenue to over $1B in revenue. WCCT Global as a company has undergone immense expansion due to the organizations advanced service offerings within multiple therapeutic areas. WCCT Global is pleased to have Dave Peters join the team as they are looking to continue this positive growth in the coming years with other acquisitions and partnerships. During his time with both organizations he negotiated and structured over 30 strategic and preferred partnership agreements with organizations ranging from small Biotech companies to large Pharmaceutical companies. He also evaluated, executed and integrated numerous acquisitions. WCCT Global's CEO Dr. Kenneth Kim stated,
"Dave's extensive wealth and experience in the CRO industry will be instrumental as we continue to provide unique service offerings for the industry. His arrival positions the company well to be the preferred full service drug development specialty CRO in the industry."
More information about WCCT Global:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, "With compassion for people, we strive for tomorrow's therapies to be available today" truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, recruitment services, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
To request more information about how WCCT Global can be of service to your organizations next clinical trial, request information Here
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global